$0.95
$0.00 (0.00%)
End-of-day quote: 05/17/2024
NasdaqGS:RIGL

Rigel Pharmaceuticals Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$115.78M $115.74M $138.74M $108.62M $59.29M $44.51M $4.48M $20.38M $28.90M $8.25M $7.15M $2.25M $4.75M $125.00M $0.75M $0.00M $12.60M $33.47M $16.53M $4.73M
GM % Gross Margin %
72.68% 46.41% 52.20% 43.85% 9.27% -6.02% 0.00% -211.27% -117.43% 0.00% 0.00% 0.00% 0.00% 61.53% 0.00% 0.00% 0.00% -70.19% -214.89% 0.00%
OM Operating Margin
-18.65% -50.14% -14.04% -26.67% -116.53% -163.30% 0.00% 0.00% -179.07% 0.00% 0.00% 0.00% 0.00% 28.25% 0.00% 0.00% 0.00% -128.60% -289.98% 0.00%
EPS Earnings Per Share
$0.00 $-0.14 $-0.34 $-0.11 $-0.18 $-0.40 $-0.44 $-0.62 $-0.67 $-0.58 $-1.04 $-1.00 $-1.32 $-1.36 $0.72 $-2.73 $-3.67 $-2.57 $-1.51 $-2.07 $-3.12
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
-0.00% -0.00% -0.00% -0.00% -0.00% -0.00% 0 0 0 -0.00% -0.00% -0.00% -0.00% 0.00% -0.00% -0.00% 0 0 0 0
Sha. Shares
174.83m 173.4m 171.6m 169.32m 167.99m 167.17m 146.81m 99.27m 90.55m 88.04m 87.52m 87.14m 71.38m 52.27m 51.96m 36.65m 31.38m 25.18m 24.81m 19.66m
OCF Operating Cash Flow
$-5.74M $-73.76M $5.88M $-52.19M $-41.51M $-58.83M $-77.56M $-75.89M $-23.41M $-69.75M $-86.08M $-85.21M $-69.38M $46.74M $-102.78M $-103.52M $-52.21M $-35.84M $-35.17M $-38.15M
FCF Free Cash Flow
$-6.67M $-74.21M $5.25M $-53.45M $-42.97M $-59.93M $-77.72M $-76.69M $-23.96M $-70.17M $-87.28M $-88.57M $-71.68M $43.18M $-102.92M $-106.03M $-53.14M $-36.75M $-36.96M $-39.70M
FCFS Free Cash Flow Per Share
$-0.12 $-0.43 $0.03 $-0.32 $-0.26 $-0.37 $-0.62 $-0.81 $-0.27 $-0.80 $-1.00 $-1.18 $-1.13 $0.83 $-2.52 $-2.94 $-1.84 $-1.47 $-1.69 $-2.20